Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 249

1.

A novel CXCR4 antagonist derived from human SDF-1beta enhances angiogenesis in ischaemic mice.

Tan Y, Li Y, Xiao J, Shao H, Ding C, Arteel GE, Webster KA, Yan J, Yu H, Cai L, Li X.

Cardiovasc Res. 2009 Jun 1;82(3):513-21. doi: 10.1093/cvr/cvp044. Epub 2009 Feb 5.

2.

Combination of stromal-derived factor-1alpha and vascular endothelial growth factor gene-modified endothelial progenitor cells is more effective for ischemic neovascularization.

Yu JX, Huang XF, Lv WM, Ye CS, Peng XZ, Zhang H, Xiao LB, Wang SM.

J Vasc Surg. 2009 Sep;50(3):608-16. doi: 10.1016/j.jvs.2009.05.049. Epub 2009 Jul 12.

3.

Bone marrow CXCR4 induction by cultivation enhances therapeutic angiogenesis.

Shiba Y, Takahashi M, Hata T, Murayama H, Morimoto H, Ise H, Nagasawa T, Ikeda U.

Cardiovasc Res. 2009 Jan 1;81(1):169-77. doi: 10.1093/cvr/cvn247. Epub 2008 Sep 12.

4.
5.

Statin and stromal cell-derived factor-1 additively promote angiogenesis by enhancement of progenitor cells incorporation into new vessels.

Shao H, Tan Y, Eton D, Yang Z, Uberti MG, Li S, Schulick A, Yu H.

Stem Cells. 2008 May;26(5):1376-84. doi: 10.1634/stemcells.2007-0785. Epub 2008 Feb 28.

6.

Efficacy of systemic administration of SDF-1 in a model of vascular insufficiency: support for an endothelium-dependent mechanism.

Carr AN, Howard BW, Yang HT, Eby-Wilkens E, Loos P, Varbanov A, Qu A, DeMuth JP, Davis MG, Proia A, Terjung RL, Peters KG.

Cardiovasc Res. 2006 Mar 1;69(4):925-35. Epub 2006 Jan 10.

7.
8.

Expression of vascular endothelial growth factor, stromal cell-derived factor-1, and CXCR4 in human limb muscle with acute and chronic ischemia.

van Weel V, Seghers L, de Vries MR, Kuiper EJ, Schlingemann RO, Bajema IM, Lindeman JH, Delis-van Diemen PM, van Hinsbergh VW, van Bockel JH, Quax PH.

Arterioscler Thromb Vasc Biol. 2007 Jun;27(6):1426-32. Epub 2007 Mar 15.

9.

Vascular endothelial growth factor and basic fibroblast growth factor induce expression of CXCR4 on human endothelial cells: In vivo neovascularization induced by stromal-derived factor-1alpha.

Salcedo R, Wasserman K, Young HA, Grimm MC, Howard OM, Anver MR, Kleinman HK, Murphy WJ, Oppenheim JJ.

Am J Pathol. 1999 Apr;154(4):1125-35.

10.

SDF-1/CXCR4 contributes to the activation of tip cells and microglia in retinal angiogenesis.

Unoki N, Murakami T, Nishijima K, Ogino K, van Rooijen N, Yoshimura N.

Invest Ophthalmol Vis Sci. 2010 Jul;51(7):3362-71. doi: 10.1167/iovs.09-4978. Epub 2010 Feb 24.

PMID:
20181837
11.

Differences in donor CXCR4 expression levels are correlated with functional capacity and therapeutic outcome of angiogenic treatment with endothelial colony forming cells.

Oh BJ, Kim DK, Kim BJ, Yoon KS, Park SG, Park KS, Lee MS, Kim KW, Kim JH.

Biochem Biophys Res Commun. 2010 Aug 6;398(4):627-33. doi: 10.1016/j.bbrc.2010.06.108. Epub 2010 Jul 1.

PMID:
20599766
12.

Evaluation of SDF-1/CXCR4-induced Ca2+ signaling by fluorometric imaging plate reader (FLIPR) and flow cytometry.

Princen K, Hatse S, Vermeire K, De Clercq E, Schols D.

Cytometry A. 2003 Jan;51(1):35-45.

13.
15.

Stromal cell-derived factor-1alpha (SDF-1alpha/CXCL12)-enhanced angiogenesis of human basal cell carcinoma cells involves ERK1/2-NF-kappaB/interleukin-6 pathway.

Chu CY, Cha ST, Lin WC, Lu PH, Tan CT, Chang CC, Lin BR, Jee SH, Kuo ML.

Carcinogenesis. 2009 Feb;30(2):205-13. doi: 10.1093/carcin/bgn228. Epub 2008 Oct 9.

16.

Stromal cell-derived factor-1 effects on ex vivo expanded endothelial progenitor cell recruitment for ischemic neovascularization.

Yamaguchi J, Kusano KF, Masuo O, Kawamoto A, Silver M, Murasawa S, Bosch-Marce M, Masuda H, Losordo DW, Isner JM, Asahara T.

Circulation. 2003 Mar 11;107(9):1322-8.

17.

Stromal cell-derived factor-1/CXCR4 enhanced motility of human osteosarcoma cells involves MEK1/2, ERK and NF-kappaB-dependent pathways.

Huang CY, Lee CY, Chen MY, Yang WH, Chen YH, Chang CH, Hsu HC, Fong YC, Tang CH.

J Cell Physiol. 2009 Oct;221(1):204-12. doi: 10.1002/jcp.21846.

PMID:
19496172
18.
19.

Blockade of the stromal cell-derived factor-1/CXCR4 axis attenuates in vivo tumor growth by inhibiting angiogenesis in a vascular endothelial growth factor-independent manner.

Guleng B, Tateishi K, Ohta M, Kanai F, Jazag A, Ijichi H, Tanaka Y, Washida M, Morikane K, Fukushima Y, Yamori T, Tsuruo T, Kawabe T, Miyagishi M, Taira K, Sata M, Omata M.

Cancer Res. 2005 Jul 1;65(13):5864-71.

20.

SDF-1 and CXCR4 are up-regulated by VEGF and contribute to glioma cell invasion.

Hong X, Jiang F, Kalkanis SN, Zhang ZG, Zhang XP, DeCarvalho AC, Katakowski M, Bobbitt K, Mikkelsen T, Chopp M.

Cancer Lett. 2006 May 8;236(1):39-45. Epub 2005 Jun 20.

PMID:
15967572
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk